How would you approach a patient with metastatic colon cancer and BRCA2 mutation in next generation sequencing?
Would you consider using PARP Inhibitor in this situation?
Answer from: Medical Oncologist at Academic Institution
We detect more mutations as more patients get next generation sequencing during their colorectal cancer treatment. The BRCA mutation is one of them.BRCA mutations are typically associated with breast, ovarian, pancreas, and prostate cancers. The relationship between BRCA mutations and colorectal can...
Comments
Medical Oncologist at University Medical Oncology Thank you very much!
Thank you very much!